Patient Compliance: Clinical Trials

35 trials for Patient Compliance, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

25 completed, 6 unknown, 2 terminated, 1 active not recruiting. 35 Phase 1, 11 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 135Completed 25, Unknown 6, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 211Completed 8, Unknown 2, Active not recruiting 1

Follow Patient Compliance: new trials by email Literature Review of Patient Compliance trials Research Report on Patient Compliance

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reducing African-American CVD Disparities Intervention Optimization (RADIO) Individuals on Statins
5 Behavioral Change Techniques - Medication Adherence
Phase 1CompletedNorthwell Health92022-08-012024-08-06
A BCT Intervention for Medication Adherence Among Individuals on Statins
5 Behavioral Change Techniques - Medication Adherence
Phase 1CompletedNorthwell Health422022-07-212024-10-15
Symptom-driven ICS/LABA Therapy for Adolescent Patients With Asthma Non-adherent to Daily Maintenance Inhalers
Maintenance ICS and Symptom Driven SABA, Symptom-driven budesonide/formoterol combination - Asthma in Children, Nonadherence, Medication
Phase 1 / Phase 2CompletedWashington University School of Medicine552022-04-012026-08-19
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
Adherence to symptom driven budesonide/formoterol as compared to adherence to maintenance ICS and symptom-driven SABA - Asthma, Nonadherence, Medication
Phase 1 / Phase 2Active not recruitingWashington University School of Medicine602021-12-162026-08-19
Clinical Guidance for Proper Treatment of Unexplained Resistant Hyperprolactinemia.
cabergoline 1.5-2 mg/week).orally daily for 1 month plus health education, cabergoline 1.5-2 mg/week).orally daily for 1 month without health education - Health Education
Phase 1CompletedWoman's Health University Hospital, Egypt1202020-02-012023-05-25
Single Dose Truvada Study
Tenofovir - Medication Adherence, HIV Prevention
Phase 1CompletedJohns Hopkins University442018-10-252020-07-16
Project Impact 2: A Culturally Tailored Smoking Cessation Intervention for Latino Smokers
Nicotine Patch, Questionnaires, Carbon Monoxide (CO) Test - Tobacco Use Cessation, Cancer Prevention
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center262015-11-022020-03-10
Feasibility of the Integrative Medication Self-Management Intervention to Promote Medication Adherence
Integrative Medication Self Management (IMedS) Intervention, Standard Care Educational Intervention - Medication Adherence, Chronic Disease
Phase 1CompletedUniversity of Wisconsin, Milwaukee342014-10-012016-03-17
Improving Medication-taking After Liver Transplant
Telemetric - Nonadherence, Tacrolimus
Phase 1CompletedIcahn School of Medicine at Mount Sinai72014-08-012016-07-01
iDropper Usability in Glaucoma
Open angle glaucoma - iDropper device - Glaucoma, Open-Angle [C11.525.381.407]
Phase 1WithdrawnCare Team Solutions2014-04-012015-12-08
QOL, ADL and Pain Before and After Intervention With N3 From Krill With D3.
Omega Krill with D3 - Quality of Life, Pain
Phase 1UnknownHospitalet Valdemar552013-02-012013-12-11
Impact of Health Education on School Children
Health Education package - Intestinal Helminthiasis
Phase 1CompletedUniversity of Malaya3172012-07-012014-06-24
Tailored Intervention to Promote Positive Airway Pressure Adherence
Tailored, Usual care - Sleep Apnea, Obstructive, Patient Compliance
Phase 1CompletedMilton S. Hershey Medical Center1182011-11-012016-11-23
An Enhanced Medication Monitoring Program
MedMinder System, MedMinder System - deactivated - Medication Adherence, Hypertension
Phase 1UnknownMedMinder Systems Inc.1502011-09-012011-11-08
Nurse Delivered Cell Phone Adherence Intervention (Pick It UP)
Adherence Counseling, General Health Counseling, Text Messages - Medication Adherence
Phase 1 / Phase 2CompletedUniversity of Connecticut6002011-07-012014-12-03
Statin Therapy to Improve Medication Adherence
Genetic testing and reporting for SLCO1B1*5 allele - Hypercholesterolemia, HMG COA Reductase Inhibitor Adverse Reaction
Phase 1CompletedDuke University632011-05-012015-01-08
Interactive Medication Reconciliation By Secure Messaging
Participants will receive a internet based secure message confirming adherence to post-discharge medication regimen - Rate of Post-discharge Medication Adherence
Phase 1UnknownVA Boston Healthcare System1522011-04-012014-03-27
Pilot Program to Improve Statin Adherence and Lower Cholesterol in Older Adults
Medication adherence intervention, Attention-control - Hypercholesterolemia, Medication Adherence
Phase 1 / Phase 2CompletedUniversity of Missouri-Columbia432010-10-012016-10-24
Caregivers and Electronic Medication Monitoring in Chronic Kidney Disease
Electronic Pillbox Monitoring System - Chronic Kidney Disease, Medication Adherence
Phase 1 / Phase 2UnknownHarvard Pilgrim Health Care602009-11-012011-06-22
"Information Technology Methodology for Patient Motivation in Diabetes Management."
Pre-coded messages, Diabetes Treatment - Type 2 Diabetes
Phase 1CompletedIndia Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals2002008-08-012011-06-27

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Medication Adherence (17)  ·  Health Education (5)  ·  Acquired Immunodeficiency Syndrome (3)  ·  HIV Infections (3)  ·  Health Behavior (3)  ·  Substance-Related Disorders (3)  ·  Alcoholism (2)  ·  Chronic Disease (2)  ·  Diabetes Mellitus (2)  ·  Hypercholesterolemia (2)  ·  Hypertension (2)  ·  Motor Activity (2)  ·  Obesity (2)  ·  Acute Coronary Syndrome (1)

Broader conditions

Behavior (35)  ·  Patient Acceptance of Health Care (35)  ·  Treatment Adherence and Compliance (35)  ·  Health Behavior (32)  ·  Immune System Diseases (6)  ·  Infections (6)  ·  Nutritional and Metabolic Diseases (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Urogenital Diseases (6)  ·  Adherence Interventions (5)  ·  Blood-Borne Infections (5)  ·  Communicable Diseases (5)  ·  Genital Diseases (5)  ·  Immunologic Deficiency Syndromes (5)

Interventions

Behavior Therapy (1)  ·  Cabergoline (1)  ·  Carbon Monoxide (1)  ·  Cognitive Behavioral Therapy (1)  ·  Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination (1)  ·  Formoterol Fumarate (1)  ·  Genetic Testing (1)  ·  Methods (1)  ·  Mindfulness-Based Stress Reduction (1)  ·  Motivational Interviewing (1)  ·  Nonoxynol (1)  ·  Precision Medicine (1)  ·  Preventive Health Services (1)  ·  Saline Solution (1)  ·  Standard of Care (1)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (2)  ·  Northwell Health (2)  ·  Washington University School of Medicine (2)  ·  Arizona State University (1)  ·  Care Team Solutions (1)  ·  Columbia University (1)  ·  Duke University (1)  ·  Hadassah Medical Organization (1)  ·  Harvard Pilgrim Health Care (1)  ·  Hospitalet Valdemar (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  India Diabetes Research Foundation & Dr. A. Ramachandran's Diabetes Hospitals (1)  ·  Johns Hopkins University (1)  ·  Lady Reading Hospital, Pakistan (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (25)  ·  Canada (1)  ·  Denmark (1)  ·  Egypt (1)  ·  India (1)  ·  Malaysia (1)  ·  Pakistan (1)

Top investigators

Ahmed K. Al-Delaimy, MSc (1)  ·  Alan L Mendelsohn, MD (1)  ·  Amy M Sawyer, PhD (1)  ·  Ashley J Beard, PhD (1)  ·  Atef M Darwish, Prof (1)  ·  Aude Henin, Ph.D. (1)  ·  Benard P Dreyer, MD (1)  ·  Christopher N Sciamanna, MD (1)  ·  Connie Celum (1)  ·  Connie M Trinacty, PhD (1)  ·  Craig Hendrix (1)  ·  Deepak Voora, MD (1)  ·  Edmond Wickham, M.D. (1)  ·  Eyal Shemesh, MD (1)  ·  Heather Kitzman, MPH (1)

Results publications

PMID 16818482, PMID 18762597, PMID 19255065, PMID 23817284, PMID 24212451, PMID 25890676, PMID 26539678, PMID 27767947, PMID 29246264, PMID 30633744, PMID 36471430, PMID 37573428

NIH funding

KL2TR002346 (2), UL1TR002345 (2), K01CA160670 (1), K07CA091976 (1), K24HL084034 (1), P30AG063786 (1), P50DA009241 (1), R00NR011173 (1), R01NR008911 (1), R01NR012962 (1), R21AT003102 (1), R34MH081335 (1), R43AI052634 (1), R43EY023122 (1)